Balyasny Asset Management LLC Adamas Pharmaceuticals, Inc. Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
Shares
4 transactions
About Adamas Pharmaceuticals, Inc.
- Ticker ADMS
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,408,100
- Market Cap $376M